JLK's Stroke AI 'JLK-NCCT' Receives FDA Approval
Screening Suspected LVO Patients with NCCT
Expanded Analysis Range Covering ICA, M1, and M2
JLK, a medical artificial intelligence (AI) company, has received approval from the U.S. Food and Drug Administration (FDA) for its non-contrast CT-based stroke analysis solution.
On March 26, JLK announced that 'JLK-NCCT' has received FDA 510(k) clearance.
This solution is capable of detecting intracranial hemorrhage using non-contrast CT (NCCT) images and identifying patients suspected of large vessel occlusion (LVO). It is designed to enable the detection of LVO, which is typically evaluated using CT angiography (CTA), during the initial screening stage.
In performance evaluations, the solution achieved a sensitivity of 78.5% and a specificity of 90.3%, surpassing the results of radiology specialists (sensitivity of 56.8% and specificity of 84.0%). Another notable feature is the expanded analysis range, which includes not only the internal carotid artery (ICA) and the M1 segment of the middle cerebral artery, but also the peripheral M2 segment.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Non-contrast CT is the first imaging test performed in most stroke patients. The company plans to leverage this product to secure patient triage capabilities at the early diagnostic stage and to expand its AI-based workflow into subsequent diagnostic and treatment steps such as CTA and MRI.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.